Back to today’s briefing

Story perspectives

UK Trial Offers Hope for Personalized Bile Duct Cancer Treatment

1/16/2025

49 5

Summary

Story summary

In a groundbreaking effort to combat bile duct cancer, UK doctors are leading the SAFIR-ABC10 trial, which tailors treatment to individual tumors using seven targeted therapies. Early results are encouraging, with patients potentially entering remission or becoming operable. With around 800 participants worldwide, this trial aims to revolutionize personalized cancer care.

1 of 1

Story summary

In a groundbreaking effort to combat bile duct cancer, UK doctors are leading the SAFIR-ABC10 trial, which tailors treatment to individual tumors using seven targeted therapies. Early results are encouraging, with patients potentially entering remission or becoming operable. With around 800 participants worldwide, this trial aims to revolutionize personalized cancer care.